Tuberculosis risk factors: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
Mohamed riad (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tuberculosis}} | {{Tuberculosis}} | ||
{{CMG}}; {{AE}} {{JS}} | {{CMG}}; {{AE}} {{Mashal Awais}}; {{JS}} | ||
==Overview== | ==Overview== | ||
The [[risk factor]]s for | The [[risk factor]]s for developing [[tuberculosis]] include: living or traveling to [[Endemic (epidemiology)|endemic]] areas for TB, elderly people and infants, [[immunosuppression]], history of frequent or prolonged contact with [[infected]] patients, IV drug users, [[smoking]], bad [[hygiene]], and poor [[nutrition]]. In addition, the [[Risk factor|risk factors]] for [[multidrug-resistant TB]] include: [[non-adherence]] to [[treatment]] [[regimen]], inadequate [[treatment]] for that [[Bacteria|bacterial]] [[strain]], and [[Contact dermatitis|contact]] with patients with [[multidrug-resistant TB]]. | ||
Risk factors for [[multidrug-resistant TB]] include: non-adherence to treatment regimen, inadequate | |||
==Risk Factors== | ==Risk Factors== | ||
Primary [[TB]] | Primary [[TB]], which represents 1-5% cases, occurs after [[infection]]. However, most of the cases occur with latent [[infection]] which is [[asymptomatic]]. The [[dormant]] [[bacilli]] can cause [[tuberculosis]] in 2 to 23% of the latent cases, usually several years following the primary [[infection]].<ref name="Parrish_1998">{{cite journal |author=Parrish N, Dick J, Bishai W |title=Mechanisms of latency in Mycobacterium tuberculosis |journal=Trends Microbiol |volume=6 |issue=3 |pages=107-12 |year=1998 | pmid = 9582936}}</ref> The risk of [[reactivation]] is much higher with [[immunosuppression]], such as [[HIV]]. In patients with [[HIV]] coinfection, the risk of [[reactivation]] increases reaching up to 10% per year. | ||
''The following are risk factors for active [[TB]]:''<ref name=CDC>{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref><ref name=Griffith_1996>{{cite journal |author=Griffith D, Kerr C |title=Tuberculosis: disease of the past, disease of the present |journal=J Perianesth Nurs |volume=11 |issue=4 |pages=240-5 |year=1996 | pmid = 8964016}}</ref> | ''The following are [[Risk factor|risk factors]] for active [[TB]]:''<ref name="CDC">{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref><ref name="Griffith_1996">{{cite journal |author=Griffith D, Kerr C |title=Tuberculosis: disease of the past, disease of the present |journal=J Perianesth Nurs |volume=11 |issue=4 |pages=240-5 |year=1996 | pmid = 8964016}}</ref> | ||
''The risk of contracting [[TB]] increases in cases where there is:''<ref name=CDC>{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref> | *Living or traveling to [[Endemic (epidemiology)|endemic]] areas (Sub-saharan African, Russia, India, Pakistan, China) | ||
* Frequent contact with people who have [[TB]] | *[[Old age|Elderly]] | ||
* Poor [[nutrition]] | *[[Infant|Infants]] | ||
* Smoking | *[[IV drug users]] | ||
* Bad hygiene | *[[Immunosuppression]]: | ||
:*[[AIDS]] | |||
:*[[Diabetes]] | |||
:*[[Silicosis]] | |||
:*[[Malignancy]], such as head and neck [[Cancer|cancers]] | |||
*[[hematology|Hematologic]] and [[Reticuloendothelial system|reticuloendothelial]] disease, such as [[leukemia]] and [[Hodgkin's disease]] | |||
:*[[End-stage kidney disease]] | |||
:*History of [[gastrectomy]] | |||
:*[[Malabsorption syndrome]] | |||
*Or those taking medications, such as: | |||
:*[[Chemotherapy]] | |||
:*[[Immunosuppressive]] medications, such as prolonged [[corticosteroid]] therapy, [[tumor necrosis factor-alpha]] blockers<ref name="Mutlu_2006">{{cite journal |author=Mutlu G, Mutlu E, Bellmeyer A, Rubinstein I |title=Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy |journal=Am J Med |volume=119 |issue=8 |pages=639-46 |year=2006 | pmid = 16887405}}</ref> | |||
:*[[Tocilizumab]] | |||
''The risk of contracting [[TB]] increases in cases where there is:''<ref name="CDC">{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref> | |||
*Frequent or prolonged contact with people who have [[TB]] | |||
*Poor [[nutrition]] | |||
*[[Smoking]] | |||
*Bad hygiene | |||
The following factors may increase the rate of [[TB]] [[infection]] in a population:<ref name="CDC">{{cite web | title = Tuberculosis Fact Sheet | url = http://www.cdc.gov/tb/publications/factsheets/drtb/mdrtb.htm }}</ref> | |||
*[[Chest X-ray]] with evidence of previous [[TB]] disease (fibrotic lesions and nodules) | |||
*Increased number of [[HIV]] infections | |||
*Increased number of [[homeless]] people | |||
*The appearance of [[drug-resistant]] [[Strain (biology)|strains]] of [[TB]] | |||
==Drugs With Increased Risk of Tuberculosis Reactivation== | ==Drugs With Increased Risk of Tuberculosis Reactivation== | ||
* Treatment with the following drugs have been reported with increased risk of reactivation of latent tuberculosis. | |||
:* [[Adalimumab]] | *Treatment with the following [[:Category:Drugs|drugs]] have been reported with increased risk of reactivation of [[latent tuberculosis]]. | ||
:* [[Alemtuzumab]] | |||
:* [[Belatacept]] | :*[[Adalimumab]] | ||
:* [[Certolizumab pegol]] | :*[[Alemtuzumab]] | ||
:* [[Canakinumab]] | :*[[Belatacept]] | ||
:* [[Etanercept]] | :*[[Certolizumab pegol]] | ||
:* [[Fluocortolone]] | :*[[Canakinumab]] | ||
:* [[Golimumab]] | :*[[Etanercept]] | ||
:* [[Infliximab]] | :*[[Fluocortolone]] | ||
:* [[Rilonacept]] | :*[[Golimumab]] | ||
:* [[Ruxolitinib]] | :*[[Infliximab]] | ||
:* [[Saxagliptin]] | :*[[Rilonacept]] | ||
:* [[Teriflunomide]] | :*[[Ruxolitinib]] | ||
:* [[Tocilizumab]] | :*[[Saxagliptin]] | ||
:* [[Tofacitinib]] | :*[[Teriflunomide]] | ||
:* | :*[[Tocilizumab]] | ||
:*[[Tofacitinib]] | |||
:*Vedolizumab | |||
===Multidrug-Resistant Tuberculosis=== | ===Multidrug-Resistant Tuberculosis=== | ||
[[Drug resistance]] is more common in people who:<ref name=WHO>{{cite web | title = Multidrug-resistant tuberculosis | url = http://www.who.int/tb/challenges/mdr/en/ }}</ref> | [[Drug resistance]] is more common in people who:<ref name="WHO">{{cite web | title = Multidrug-resistant tuberculosis | url = http://www.who.int/tb/challenges/mdr/en/ }}</ref> | ||
* Do not take their [[TB]] medicine regularly | |||
* Do not take all of their [[TB]] medicine as told by their doctor or nurse | *Do not take their [[TB]] medicine regularly | ||
* Develop [[TB]] disease again, after having taken [[TB]] medicine in the past | *Do not take all of their [[TB]] medicine as told by their doctor or nurse | ||
* Come from areas of the world where [[drug-resistant]] [[TB]] is common | *Develop [[TB]] disease again, after having taken [[TB]] medicine in the past | ||
* Have spent time with someone known to have [[drug-resistant]] [[TB]] disease | *Come from areas of the world where [[drug-resistant]] [[TB]] is common | ||
*Have spent time with someone known to have [[drug-resistant]] [[TB]] disease | |||
==References== | ==References== | ||
| Line 75: | Line 86: | ||
[[Category:Bacterial diseases]] | [[Category:Bacterial diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category: Pulmonology]] | |||
[[Category:Pulmonology | |||
Latest revision as of 06:35, 22 March 2021
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberculosis risk factors On the Web |
|
American Roentgen Ray Society Images of Tuberculosis risk factors |
|
Risk calculators and risk factors for Tuberculosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mashal Awais, M.D.[2]; João André Alves Silva, M.D. [3]
Overview
The risk factors for developing tuberculosis include: living or traveling to endemic areas for TB, elderly people and infants, immunosuppression, history of frequent or prolonged contact with infected patients, IV drug users, smoking, bad hygiene, and poor nutrition. In addition, the risk factors for multidrug-resistant TB include: non-adherence to treatment regimen, inadequate treatment for that bacterial strain, and contact with patients with multidrug-resistant TB.
Risk Factors
Primary TB, which represents 1-5% cases, occurs after infection. However, most of the cases occur with latent infection which is asymptomatic. The dormant bacilli can cause tuberculosis in 2 to 23% of the latent cases, usually several years following the primary infection.[1] The risk of reactivation is much higher with immunosuppression, such as HIV. In patients with HIV coinfection, the risk of reactivation increases reaching up to 10% per year.
The following are risk factors for active TB:[2][3]
- Living or traveling to endemic areas (Sub-saharan African, Russia, India, Pakistan, China)
- Elderly
- Infants
- IV drug users
- Immunosuppression:
- AIDS
- Diabetes
- Silicosis
- Malignancy, such as head and neck cancers
- Hematologic and reticuloendothelial disease, such as leukemia and Hodgkin's disease
- Or those taking medications, such as:
- Chemotherapy
- Immunosuppressive medications, such as prolonged corticosteroid therapy, tumor necrosis factor-alpha blockers[4]
- Tocilizumab
The risk of contracting TB increases in cases where there is:[2]
The following factors may increase the rate of TB infection in a population:[2]
- Chest X-ray with evidence of previous TB disease (fibrotic lesions and nodules)
- Increased number of HIV infections
- Increased number of homeless people
- The appearance of drug-resistant strains of TB
Drugs With Increased Risk of Tuberculosis Reactivation
- Treatment with the following drugs have been reported with increased risk of reactivation of latent tuberculosis.
Multidrug-Resistant Tuberculosis
Drug resistance is more common in people who:[5]
- Do not take their TB medicine regularly
- Do not take all of their TB medicine as told by their doctor or nurse
- Develop TB disease again, after having taken TB medicine in the past
- Come from areas of the world where drug-resistant TB is common
- Have spent time with someone known to have drug-resistant TB disease
References
- ↑ Parrish N, Dick J, Bishai W (1998). "Mechanisms of latency in Mycobacterium tuberculosis". Trends Microbiol. 6 (3): 107–12. PMID 9582936.
- ↑ 2.0 2.1 2.2 "Tuberculosis Fact Sheet".
- ↑ Griffith D, Kerr C (1996). "Tuberculosis: disease of the past, disease of the present". J Perianesth Nurs. 11 (4): 240–5. PMID 8964016.
- ↑ Mutlu G, Mutlu E, Bellmeyer A, Rubinstein I (2006). "Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy". Am J Med. 119 (8): 639–46. PMID 16887405.
- ↑ "Multidrug-resistant tuberculosis".